World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
40046
World Ranking
7349
National Ranking
415

Research.com Recognitions

  • 2020 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Radiology

Overview

Uwe Haberkorn is affiliated with Heidelberg University in Germany. Their research focuses primarily on medicine, with specific emphasis on oncology, radiology, nuclear medicine, and imaging. Haberkorn's work spans several subfields, including pulmonary and respiratory medicine, surgery, and cancer research.

The scientist's research covers a range of topics that include:

  • Peptidase Inhibition and Analysis
  • Protease and Inhibitor Mechanisms
  • Radiopharmaceutical Chemistry and Applications
  • Cardiac Structural Anomalies and Repair
  • Prostate Cancer Treatment and Research
  • Medical Imaging Techniques and Applications
  • Neuropeptides and Animal Physiology

Haberkorn has contributed to several peer-reviewed publications. Significant recent papers include:

  • "E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET" (2021) published in the European Journal of Nuclear Medicine and Molecular Imaging
  • "PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0" (2023) published in the European Journal of Nuclear Medicine and Molecular Imaging
  • "FAPI-74 PET/CT Using Either18F-AlF or Cold-Kit68Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients" (2020) published in the Journal of Nuclear Medicine
  • "FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease" (2023) published in Radiology
  • "The Latest Developments in Imaging of Fibroblast Activation Protein" (2020) published in the Journal of Nuclear Medicine

The main publication venues where Haberkorn has frequently contributed are:

  • European Journal of Nuclear Medicine and Molecular Imaging
  • Journal of Nuclear Medicine
  • Nuklearmedizin - NuclearMedicine
  • Radiotherapy and Oncology
  • Cancers

Frequent co-authors in Haberkorn's research include:

  • Frederik L. Giesel
  • Clemens Kratochwil
  • Jürgen Debus
  • Manuel Röhrich
  • Stefan A. Koerber

In 2020, Haberkorn was awarded membership in the German National Academy of Sciences Leopoldina, reflecting recognition within the scientific community related to radiology.

Best Publications

  • 68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer

    Clemens Kratochwil;Paul Flechsig;Thomas Lindner;Labidi Abderrahim

  • The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

    Ali Afshar-Oromieh;Eleni Avtzi;Frederik L. Giesel;Tim Holland-Letz

  • Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer

    Ali Afshar-Oromieh;Christian M. Zechmann;Anna Malcher;Matthias Eder

  • PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.

    A. Afshar-Oromieh;A. Malcher;M. Eder;Michael Eisenhut

  • German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients.

    Kambiz Rahbar;Hojjat Ahmadzadehfar;Clemens Kratochwil;Uwe Haberkorn

  • 68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging

    Matthias Eder;Martin Schäfer;Ulrike Bauder-Wüst;William Edmund Hull

  • Performance Evaluation of a Whole-Body PET Scanner Using the NEMA Protocol

    Gunnar Brix;Joachim Zaers;Lars Eric Adam;Matthias E. Bellemann

  • Remission of Major Depression Under Deep Brain Stimulation of the Lateral Habenula in a Therapy-Refractory Patient

    Alexander Sartorius;Karl L. Kiening;Peter Kirsch;Carl C. von Gall

  • PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617

    Clemens Kratochwil;Frederik L. Giesel;Melsa Stefanova;Martina Benešová

  • A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts.

    Anastasia Loktev;Anastasia Loktev;Anastasia Loktev;Thomas Lindner;Walter Mier;Jürgen Debus;Jürgen Debus

  • Preclinical evaluation of a tailor-made DOTA-conjugated PSMA inhibitor with optimized linker moiety for imaging and endoradiotherapy of prostate cancer

    Martina Benešová;Martin Schäfer;Ulrike Bauder-Wüst;Ali Afshar-Oromieh

  • Methylglyoxal modification of Na v 1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy

    Angelika Bierhaus;Thomas Fleming;Stoyan Stoyanov;Andreas Leffler;Andreas Leffler

  • Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients.

    Ali Afshar-Oromieh;Ali Afshar-Oromieh;Tim Holland-Letz;Frederik L. Giesel;Clemens Kratochwil

  • Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.

    Joerg Petersen;Maura Dandri;Walter Mier;Marc Lütgehetmann

  • Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer

    Matthias Eder;Oliver Neels;Miriam Müller;Ulrike Bauder-Wüst

  • Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control

    Clemens Kratochwil;Frank Bruchertseifer;Hendrik Rathke;Markus Hohenfellner

  • Evaluation of Positron Emission Tomography Imaging Using [68Ga]-DOTA-D Phe1-Tyr3-Octreotide in Comparison to [111In]-DTPAOC SPECT. First Results in Patients with Neuroendocrine Tumors

    Jörg Kowalski;Marcus Henze;Marcus Henze;Jochen Schuhmacher;Helmut R Mäcke

  • The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions

    Ali Afshar-Oromieh;Ali Afshar-Oromieh;Henrik Hetzheim;Clemens Kratochwil;Martina Benesova

  • Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding.

    Clemens Kratochwil;Frank Bruchertseifer;Hendrik Rathke;Marcus Bronzel

  • Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience.

    A. Afshar-Oromieh;A. Afshar-Oromieh;U. Haberkorn;U. Haberkorn;H. P. Schlemmer;M. Fenchel

Frequent Co-Authors

Walter Mier
Walter Mier University Hospital Heidelberg
Frederik L. Giesel
Frederik L. Giesel University Hospital Heidelberg
Jürgen Debus
Jürgen Debus University Hospital Heidelberg
Heinz-Peter Schlemmer
Heinz-Peter Schlemmer German Cancer Research Center
John W. Babich
John W. Babich Cornell University
Dirk Koczan
Dirk Koczan University of Rostock
Hartmut Goldschmidt
Hartmut Goldschmidt University Hospital Heidelberg
Michael V. Knopp
Michael V. Knopp The Ohio State University Wexner Medical Center
Dirk Jäger
Dirk Jäger Heidelberg University
Christel Herold-Mende
Christel Herold-Mende Heidelberg University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're exploring alternative healthcare careers or flexible education pathways, there are several online degree options worth considering. Some students may find a quicker entry into the healthcare field through entry level msn programs online, which are tailored for non-nurses looking to transition into nursing with an advanced degree.

For those focused on accessibility, the question of what is the easiest nursing school to get into is common. Some nursing programs offer less competitive admissions criteria, making them more reachable for students with varied academic backgrounds.

Outside of clinical roles, many learners are pursuing medical coding and billing classes online with financial aid. These programs offer training for essential behind-the-scenes roles in healthcare administration, often with financial support available.

Lastly, if standardized testing is a concern, there are options such as an lpn program no entrance exam required, making entry into the nursing workforce more accessible for many students.

Best Scientists Citing Uwe Haberkorn

Trending Scientists